5 mg/ml
Trade Name
Bupivacaine For Spinal Anesthesia Aguettant
Solution for injection
Request Type
New Registration
Drug Type
NCE
Approval Date
SFDA Approved Use
Bupivacaine is indicated in adults and children of all ages for intrathecal (subarachnoid) spinal anaesthesia for surgery (urological and lower limb surgery lasting 2–3 hours, abdominal surgery lasting 45–60 minutes).
Bupivacaine is a long-acting anaesthetic agent of the amide type. BUPIVACAINE has a rapid onset of action and long duration. The duration of analgesia in the T10–T12 segments is 2–3 hours.
BUPIVACAINE produces a moderate muscular relaxation of the lower extremities lasting 2–2.5 hours. The motor blockade of the abdominal muscles makes the solution suitable for performance of abdominal surgery lasting 45–60 minutes. The duration of the motor blockade does not exceed the duration of analgesia. The cardiovascular effects of BUPIVACAINE are similar or less than those seen with other spinal agents. Bupivacaine 5 mg/ml with glucose 80 mg/ml is exceptionally well tolerated by all tissues with which it comes in contact.
Bupivacaine is a long-acting anaesthetic agent of the amide type. BUPIVACAINE has a rapid onset of action and long duration. The duration of analgesia in the T10–T12 segments is 2–3 hours.
BUPIVACAINE produces a moderate muscular relaxation of the lower extremities lasting 2–2.5 hours. The motor blockade of the abdominal muscles makes the solution suitable for performance of abdominal surgery lasting 45–60 minutes. The duration of the motor blockade does not exceed the duration of analgesia. The cardiovascular effects of BUPIVACAINE are similar or less than those seen with other spinal agents. Bupivacaine 5 mg/ml with glucose 80 mg/ml is exceptionally well tolerated by all tissues with which it comes in contact.